Wednesday, May 17 2023
08:01 AM – 08:25 AM PT
Discovery and Characterization of Novel Cross-Species BBB-Penetrant Capsids
Brett Hoffman, PhD. Voyager Therapeutics, Cambridge, MA
Disclosures: B. Hoffman: 1; Commercial Interest i.e. Company X; Voyager Therapeutics. 1; What was received? i.e. Honorarium; Salary & Stock. 1; For what role? i.e. Speaker; Employee.